A New Step Forward for Biosimilar Access GlycoNex Inc. has officially announced a significant milestone in its product development pipeline. The company has successfully submitted a New Drug Application (NDA) to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for SPD8, their highly anticipated denosumab biosimilar. Understanding the Significance of SPD8 Denosumab is a…